Literature DB >> 10081525

Ozone-induced lung inflammation and mucosal barrier disruption: toxicology, mechanisms, and implications.

D K Bhalla1.   

Abstract

The airway epithelial lining serves as an efficient barrier against penetration of exogenous particles and macromolecules. Disruption of this barrier following O3 exposure represents a state of compromised epithelial defenses leading to increased transmucosal permeability. Although the barrier disruption following an acute exposure is transient in nature, the brief period of disruption caused by O3, an oxidant air pollutant, provides an opportunity for facilitated entry of a potentially toxic particulate copollutant(s) across the airway epithelia. The subsequent deposition and retention of the copollutant(s) in the subepithelial compartment for prolonged periods adds the risk of injury due to chronic exposure following an acute episode. Toxicological studies from several laboratories have demonstrated alterations in epithelial permeability, suggestive of barrier disruption, in animals and humans exposed to O3. Inflammatory cells represent another important component of pulmonary defenses, but upon activation these cells can both induce and sustain injury. The recruitment of these cells into the lung following O3 exposure presents a risk of tissue damage through the release of toxic mediators by activated inflammatory cells. Several studies have reported concomitant changes in permeability and recruitment of the inflammatory cells in the lung following O3 exposure. In these studies, an inflammatory response, as detected by an increase in the number of polymorphonuclear leukocytes in the bronchoalveolar lavage (BAL) or in lung parenchyma, was accompanied by either an increased tracer transport across the airway mucosa or an elevation in the levels of total protein and/or albumin in the BAL. The magnitude of response and the time at which the permeability changes and inflammatory response peaked varied with O3 concentration, exposure duration, and the mode of analysis. The responsiveness to O3 also appeared to vary with the animal species, and increased under certain conditions such as physical activity and pregnancy. Some of the effects seen after an acute exposure to O3 were modified upon repeated exposures. The responses following repeated exposures included attenuation, persistence, or elevation of permeability and inflammation. Mechanistic studies implicate chemotactic factors, cellular mediators, and cell-surface-associated molecules in the induction of inflammation and lung injury. In discussing these studies, this review serves to introduce the mucosal barrier functions in the lung, evaluates inflammatory and permeability consequences of O3, addresses mechanisms of inflammatory reactions, and offers alternate viewpoints.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081525     DOI: 10.1080/109374099281232

Source DB:  PubMed          Journal:  J Toxicol Environ Health B Crit Rev        ISSN: 1093-7404            Impact factor:   6.393


  43 in total

1.  Role of TNFR1 in lung injury and altered lung function induced by the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide.

Authors:  Vasanthi R Sunil; Kinal Patel-Vayas; Jianliang Shen; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2010-11-09       Impact factor: 4.219

2.  Ozone-induced lung injury and sterile inflammation. Role of toll-like receptor 4.

Authors:  Agnieszka J Connor; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2012-01-24       Impact factor: 3.362

3.  Regulation of ozone-induced lung inflammation and injury by the β-galactoside-binding lectin galectin-3.

Authors:  Vasanthi R Sunil; Mary Francis; Kinal N Vayas; Jessica A Cervelli; Hyejeong Choi; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2015-02-25       Impact factor: 4.219

4.  Impact of aging on pulmonary responses to acute ozone exposure in mice: role of TNFR1.

Authors:  Stephanie A Shore; Erin S Williams; Lucas Chen; Leandro A P Benedito; David I Kasahara; Ming Zhu
Journal:  Inhal Toxicol       Date:  2011-11-08       Impact factor: 2.724

Review 5.  Ozone and pulmonary innate immunity.

Authors:  John W Hollingsworth; Steven R Kleeberger; W Michael Foster
Journal:  Proc Am Thorac Soc       Date:  2007-07

6.  Editor's Highlight: CCR2 Regulates Inflammatory Cell Accumulation in the Lung and Tissue Injury following Ozone Exposure.

Authors:  Mary Francis; Angela M Groves; Richard Sun; Jessica A Cervelli; Hyejeong Choi; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2016-11-11       Impact factor: 4.849

7.  Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axis.

Authors:  Michelle A Erickson; Joseph Jude; Hengjiang Zhao; Elizabeth M Rhea; Therese S Salameh; William Jester; Shelley Pu; Jenna Harrowitz; Ngan Nguyen; William A Banks; Reynold A Panettieri; Kelly L Jordan-Sciutto
Journal:  FASEB J       Date:  2017-05-22       Impact factor: 5.191

8.  Regulation of Nitrogen Mustard-Induced Lung Macrophage Activation by Valproic Acid, a Histone Deacetylase Inhibitor.

Authors:  Alessandro Venosa; James G Gow; LeRoy Hall; Rama Malaviya; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2017-05-01       Impact factor: 4.849

9.  Upregulation of phosphoinositide 3-kinase and protein kinase B in alveolar macrophages following ozone inhalation. Role of NF-kappaB and STAT-1 in ozone-induced nitric oxide production and toxicity.

Authors:  Debra L Laskin; Ladan Fakhrzadeh; Diane E Heck; Donald Gerecke; Jeffrey D Laskin
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

10.  Ozone Exposure During Implantation Increases Serum Bioactivity in HTR-8/SVneo Trophoblasts.

Authors:  Colette N Miller; Erica J Stewart; Samantha J Snow; Wanda C Williams; Judy H Richards; Leslie C Thompson; Mette C Schladweiler; Aimen K Farraj; Urmila P Kodavanti; Janice A Dye
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.